Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays

Clinical trial NCT02407561 · TERMINATED

Trial details

NCT number: NCT02407561
Sponsor: Castle Biosciences Incorporated
Status: TERMINATED
Study type: OBSERVATIONAL

Rectal Adenocarcinoma Anal Adenocarcinoma Anal Squamous Cell Carcinoma

Start date: 2015-02-01
Primary completion: 2016-07-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.